Indications for absorbable steroid‐eluting sinus implants: Viewpoint via the Delphi method

Absorbable steroid‐eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delph...

Full description

Saved in:
Bibliographic Details
Published in:International forum of allergy & rhinology 2022-10, Vol.12 (10), p.1225-1231
Main Authors: Lee, Victoria S., Patel, Prayag, O'Brien, Daniel, Scangas, George A., Campbell, Raewyn G., Chandra, Rakesh, Davis, Greg E., Han, Joseph K, Le, Christopher H., Lee, Jivianne, Luong, Amber U., Poetker, David M., Ramadan, Hassan, Setzen, Michael, Smith, Kristine, Wise, Sarah, Villwock, Jennifer, Ference, Elisabeth
Format: Article
Language:English
Subjects:
Absorbable Implants
Adrenal Cortex Hormones
Chronic Disease
Decision making
Delphi Technique
Diabetes mellitus
endoscopic sinus surgery
Endoscopy
Humans
Implants
PROPEL
Restenosis
Rhinitis - surgery
Sinusitis - surgery
SINUVA
Steroid hormones
Steroids - therapeutic use
steroid‐eluting implants
Treatment Outcome
Viewpoint
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Absorbable steroid‐eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in‐office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in‐office use of steroid‐eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case‐by‐case basis after shared decision‐making.
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.23044